SEARCH

SEARCH BY CITATION

References

  • 1
    Stetson, D. B. and Medzhitov, R., Type I interferons in host defense. Immunity 2006. 25: 373381.
  • 2
    Sadler, A. J. and Williams, B. R., Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008. 8: 559568.
  • 3
    Dunn, G. P., Koebel, C. M. and Schreiber, R. D., Interferons, immunity and cancer immunoediting. Nat. Rev. Immunol. 2006. 6: 836848.
  • 4
    Ferrantini, M., Capone, I. and Belardelli, F., Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. Biochimie 2007. 89: 884893.
  • 5
    Martinez, J., Huang, X. and Yang, Y., Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J. Immunol. 2008. 180: 15921597.
  • 6
    Sun, S., Zhang, X., Tough, D. F. and Sprent, J., Type I interferon-mediated stimulation of T cells by CpG DNA. J. Exp. Med. 1998. 188: 23352342.
  • 7
    Marrack, P., Kappler, J. and Mitchell, T., Type I interferons keep activated T cells alive. J. Exp. Med. 1999. 189: 521530.
  • 8
    Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. and Murali-Krishna, K., Type I interferons act directly on CD8lT cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 2005. 202: 637650.
  • 9
    Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T. and Belardelli, F., Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 2000. 191: 17771788.
  • 10
    Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N., Trapani, J. and Cebon, J., Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 1998. 161: 19471953.
  • 11
    Ito, T., Amakawa, R., Inaba, M., Ikehara, S., Inaba, K. and Fukuhara, S., Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 2001. 166: 29612969.
  • 12
    Blanco, P., Palucka, A. K., Gill, M., Pascual, V. and Banchereau, J., Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001. 294: 15401543.
  • 13
    Hiscott, J., Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 2007. 282: 1532515329.
  • 14
    Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G. P., Lin, R. and Hiscott, J., Triggering the interferon antiviral response through an IKK-related pathway. Science 2003. 300: 11481151.
  • 15
    Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J. et al., IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003. 4: 491496.
  • 16
    Lin, R., Mamane, Y. and Hiscott, J., Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol. Cell. Biol. 1999. 19: 24652474.
  • 17
    Lin, R., Heylbroeck, C., Pitha, P. M. and Hiscott, J., Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 1998. 18: 29862996.
  • 18
    Lin, R., Mamane, Y. and Hiscott, J., Multiple regulatory domains control IRF-7 activity in response to virus infection. J. Biol. Chem. 2000. 275: 3432034327.
  • 19
    Yoneyama, M., Suhara, W., Fukuhara, Y., Fukada, M., Nishida, E. and Fujita, T., Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 1998. 17: 10871095.
  • 20
    Servant, M. J., ten Oever, B. and Lin, R., Review: overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function. J. Interferon Cytokine Res. 2002. 22: 4958.
  • 21
    Lin, R., Genin, P., Mamane, Y. and Hiscott, J., Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 2000. 20: 63426353.
  • 22
    Au, W.-C., Moore, P. A., Lowther, W., Juang, Y.-T. and Pitha, P. M., Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 1995. 92: 1165711661.
  • 23
    Izaguirre, A., Barnes, B. J., Amrute, S., Yeow, W. S., Megjugorac, N., Dai, J., Feng, D. et al., Comparative analysis of IRf and IFN-alpha expression in human plasmocytoid and monocyte-dereived dentritic cells. J. Leukoc. Biol. 2003. 74: 11251138.
  • 24
    Sato, M., Tanaka, N., Hata, N., Oda, E. and Taniguchi, T., Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett. 1998. 425: 112116.
  • 25
    Marie, I., Durbin, J. E. and Levy, D. E., Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 1998. 17: 66606669.
  • 26
    Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T. et al., Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000. 13: 539548.
  • 27
    Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N. et al., IRF-7 is the master regulator of type-1 interferon-dependent immune responses. Nature 2005. 434: 772777.
  • 28
    Barnes, B. J., Richards, J., Mancl, M., Hanash, S., Beretta, L. and Pitha, P. M., Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J. Biol. Chem. 2004. 279: 4519445207.
  • 29
    Grandvaux, N., Servant, M. J., tenOever, B., Sen, G. C., Balachandran, S., Barber, G. N., Lin, R. and Hiscott, J., Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 2002. 76: 55325539.
  • 30
    Andersen, J., VanScoy, S, Cheng, T. F., Gomez, D. and Reich, N. C., IRF-3-dependent and augmented target genes during viral infection. Genes Immun. 2008. 9: 168175.
  • 31
    Heylbroeck, C., Balachandran, S., Servant, M. J., DeLuca, C., Barber, G. N., Lin, R. and Hiscott, J., The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J. Virol. 2000. 74: 37813792.
  • 32
    Romieu-Mourez, R., Solis, M., Nardin, A., Goubau, D., Baron-Bodo, V., Lin, R., Massie, B. et al., Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages. Cancer Res. 2006. 66: 1057610585.
  • 33
    Lallemand, C., Blanchard, B., Palmieri, M., Lebon, P., May, E. and Tovey, M. G., Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB. Oncogene 2007. 26: 328338.
  • 34
    Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T. et al., Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000. 288: 10531058.
  • 35
    Budagian, V., Bulanova, E., Paus, R. and Bulfone-Paus, S., IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006. 17: 259280.
  • 36
    Bossen, C. and Schneider, P., BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 2006. 18: 263275.
  • 37
    Luk, T., Malam, Z. and Marshall, J. C., Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J. Leukoc. Biol. 2008. 83: 804816.
  • 38
    Willis, S. N. and Adams, J. M., Life in the balance: how BH3-only proteins induce apoptosis. Curr. Opin. Cell Biol. 2005. 17: 617625.
  • 39
    Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M. et al., Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 2005. 17: 393403.
  • 40
    Sun, Y. and Leaman, D. W., Involvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA, and virus infection. J. Biol. Chem. 2005. 280: 1556115568.
  • 41
    Ortiz-Navarrete, V., Seelig, A., Gernold, M., Frentzel, S., Kloetzel, P. M. and Hammerling, G. J., Subunit of the ‘20S’ proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 1991. 353: 662664.
  • 42
    Martinez, C. K. and Monaco, J. J., Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 1991. 353: 664667.
  • 43
    Kelly, A., Powis, S. H., Glynne, R., Radley, E., Beck, S. and Trowsdale, J., Second proteasome-related gene in the human MHC class II region. Nature 1991. 353: 667668.
  • 44
    Kesmir, C., van Noort, V., de Boer, R. J. and Hogeweg, P., Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome. Immunogenetics 2003. 55: 437449.
  • 45
    Strehl, B., Textoris-Taube, K., Jakel, S., Voigt, A., Henklein, P., Steinhoff, U., Kloetzel, P. M. and Kuckelkorn, U., Antitopes define preferential proteasomal cleavage site usage. J. Biol. Chem. 2008. 283: 1789117897.
  • 46
    Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S. et al., Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003. 424: 516523.
  • 47
    Weaver, B. K., Ando, O., Kumar, K. P. and Reich, N. C., Apoptosis is promoted by the dsRNA-activated factor (DRAF1) during viral infection independent of the action of interferon or p53. FASEB J. 2001. 15: 501515.
  • 48
    Shin, E. C., Seifert, U., Kato, T., Rice, C. M., Feinstone, S. M., Kloetzel, P. M. and Rehermann, B., Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J. Clin. Invest. 2006. 116: 30063014.
  • 49
    Le Bon, A. and Tough, D. F., Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev. 2008. 19: 3340.
  • 50
    Le Bon, A. and Tough, D. F., Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 2002. 14: 432436.
  • 51
    Banchereau, J., Ueno, H., Dhodapkar, M., Connolly, J., Finholt, J. P., Klechevsky, E., Blanck, J. P. et al., Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon. J. Immunother. 2005. 28: 505516.
  • 52
    Papewalis, C., Jacobs, B., Wuttke, M., Ullrich, E., Baehring, T., Fenk, R., Willenberg, H. S. et al., IFN-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo. J. Immunol. 2008. 180: 14621470.
  • 53
    Fanger, N. A, Maliszewski, C. R., Schooley, K. and Griffith, T. S., Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med. 1999. 190: 11551164.
  • 54
    Sharif-Askari, E., Nakhaei, P., Oliere, S., Tumilasci, V., Hernandez, E., Wilkinson, P., Lin, R. et al., Bax-dependent mitochondrial membrane permeabilization enhances IRF3-mediated innate immune response during VSV infection. Virology 2007. 365: 2033.
  • 55
    Peters, K., Chattopadhyay, S. and Sen G. C., IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. J. Virol. 2008. 82: 35003508.
  • 56
    Degenhardt, K., Sundararajan, R., Lindsten, T., Thompson, C. and White, E., Bax and Bak independently promote cytochrome C release from mitochondria. J. Biol. Chem. 2002. 277: 1412714134.
  • 57
    Lin, R., Lacoste, J., Nakhaei, P., Sun, Q., Yang, L., Paz, S., Wilkinson, P. et al., Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J. Virol. 2006. 80: 60726083.
  • 58
    Sheehan, K. C., Lai, K. S., Dunn, G. P., Bruce, A. T., Diamond, M. S., Heutel, J. D., Dungo-Arthur, C. et al., Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 2006. 26: 804819.
  • 59
    Smyth, G. K., Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004. 3: 126.
  • 60
    Sturn, A., Quackenbush, J. and Trajanoski, Z., Genesis: cluster analysis of microarray data. Bioinformatics 2002. 18: 207208.
  • 61
    Porta, C., Hadj-Slimane, R., Nejmeddine, M., Pampin, M., Tovey, M. G., Espert, L., Alvarez, S. and Chelbi-Alix, M. K., Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively. Oncogene 2005. 24: 605615.
  • 62
    Solis, M., Romieu-Mourez, R., Goubau, D., Grandvaux, N., Mesplede, T., Julkunen, I., Nardin, A. et al., Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophages. Eur. J. Immunol. 2007. 37: 528539.